GENDRON PAUL ANDREW 4

What Happened

• Paul Gendron, a director of InfuSystem Holdings, Inc. (INFU), received a grant of an option representing the right to purchase 24,890 shares on May 12, 2026. The Form 4 reports an acquisition price of $0.00 and classifies the transaction as an award/grant (derivative security). The option vests on May 12, 2027 (see footnote).

Key Details

• Transaction date: 2026-05-12; Form 4 filed: 2026-05-14 (timely filing).
• Grant: option for 24,890 shares; reported acquisition price: $0.00.
• Vesting: option vests on 2027-05-12 (per footnote).
• Shares owned after transaction: not disclosed in this filing.
• Footnote: "The option, representing the right to purchase 24,890 shares ... vests on May 12, 2027."
• Filing status: timely (no late filing indicated).

Context

• This was an equity award (option grant), not an open-market purchase or sale. Options give the right to buy shares in the future if and when exercised; they do not represent immediate ownership or a cash sale. Because the filing does not disclose an exercise/strike price or any immediate cash value, the award's economic value to the insider depends on future stock price and any exercise terms. Awards to directors are often routine compensation and should not be read as a direct buy/sell signal.